Home/Filings/4/0001104659-19-002543
4//SEC Filing

Myer Vickesh 4

Accession 0001104659-19-002543

CIK 0001650664other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 8:58 PM ET

Size

14.5 KB

Accession

0001104659-19-002543

Insider Transaction Report

Form 4
Period: 2019-01-17
Myer Vickesh
Chief Technology Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-01-18$11.21/sh+4,000$44,8404,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-01-173,00079,307 total
    Exercise: $0.65Exp: 2025-04-29Common Stock (3,000 underlying)
  • Sale

    Common Stock

    2019-01-17$26.18/sh3,000$78,5400 total
  • Exercise/Conversion

    Common Stock

    2019-01-17$0.65/sh+3,000$1,9503,000 total
  • Sale

    Common Stock

    2019-01-18$26.50/sh4,000$106,0000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-01-184,00052,897 total
    Exercise: $11.21Exp: 2025-10-29Common Stock (4,000 underlying)
Footnotes (4)
  • [F1]The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017.
  • [F2]This transaction was executed in multiple trades at prices ranging from $26.03 to $26.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected.
  • [F3]This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019.
  • [F4]This option was granted on October 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on October 27, 2016 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019.

Documents

1 file

Issuer

Editas Medicine, Inc.

CIK 0001650664

Entity typeother

Related Parties

1
  • filerCIK 0001742806

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 8:58 PM ET
Size
14.5 KB